Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|13|10|1013-1020
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.13, Iss.10, 2007-04, pp. : 1013-1020
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Angiogenesis as Risk Factor for Plaque Vulnerability
Current Pharmaceutical Design, Vol. 15, Iss. 10, 2009-04 ,pp. :
Access to resources
Recommend
Mice in Ecstasy: Advanced Animal Models in the Study of MDMA
Current Pharmaceutical Biotechnology, Vol. 11, Iss. 5, 2010-08 ,pp. :
Update on the Evidence of Statin Treatment to Reduce Plaque Vulnerability
Drug Metabolism Letters, Vol. 6, Iss. 3, 2012-09 ,pp. :
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. :